Preliminary study finds a clue in the quest to help diagnose CTE in the living
Summary
Researchers found that levels of a tau protein fragment were higher in samples from people with advanced chronic traumatic encephalopathy (CTE) than in healthy people. The early finding did not reliably identify early-stage CTE and needs testing in much larger studies.Key Facts
- CTE is linked to repeated blows to the head and can only be confirmed by examining the brain after death.
- Symptoms such as mood swings and memory loss can also occur in other diseases.
- Researchers at Washington University in St. Louis studied a tau fragment called eMTBR-tau243.
- They first noticed high levels of the fragment in a person with advanced CTE who did not have Alzheimer's disease.
- The researchers later tested stored blood from 11 people classified as having CTE.
- Levels of eMTBR-tau243 were higher in people with advanced CTE than in healthy people.
- The biomarker could not reliably identify early-stage CTE.
- The findings were published in JAMA and presented at a scientific meeting in Japan.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.